Breaking News
Donald Trump, the National LP convention, and the LP Fundraising Scheme
This is honestly insane.
Appeals Court Hammers Prosecution about FBI Conduct in Whitmer Kidnap Plot
400 Legend Ballistics From The Leading Ammunition Manufacturer
Top Tech News
The first reverse microwave in the U.S.: you can have it at home to save energy while cooking
BREAKTHROUGH : Lightsolver Makes Ultrafast Laser Based Computers
$300,000 robotic micro-factories pump out custom-designed homes
$300,000 robotic micro-factories pump out custom-designed homes
Skynet Has Arrived: Google Follows Apple, Activates Worldwide Bluetooth LE Mesh Network
The Car Fueled Entirely by the Sun Takes Huge Step Towards Production
A new wave of wearable devices will collect a mountain on information on us...
Star Trek's Holodeck becomes reality thanks to ChatGPT and video game technology
Blazing bits transmitted 4.5 million times faster than broadband
Rewiring
Tumor-Destroying Sound Waves Treatment Coming to a Hospital Near You For Liver Cancer
Known as "histotripsy," the method and machinery have already been tested successfully in animals and humans, and has just been approved for use by the FDA.
HistoSonics is a company founded in 2009 to create an ultrasound device that both screens for tumors and administers histotripsy. It was born from the efforts of scientists at the University of Michigan who co-founded the firm.
"Histotripsy is an exciting new technology that, although it is in early stages of clinical use, may provide a noninvasive treatment option for patients with liver cancer. Hopefully it can be combined with systemic therapies for a synergistic therapeutic effect," said Mishal Mendiratta-Lala, professor of radiology with Michigan Medicine.
Mendiratta-Lala was the principal investigator of an FDA human trial started in 2021 which confirmed that HistoSonic's device, called Edison, can destroy cancer tumors.